What's the main reason the PicoWay® system is the laser of choice for so many of the world's leading tattoo removal chains and specialist skin & laser clinics?
With proven results in the above four FDA-cleared indications, the PicoWay® system allows you to attract a wide range of patients of all skin types. Discover more in the newly available digital version of our popular PicoWay® Clinical Results book, which documents 54 PicoWay® treatments, with before & after photos and detailed treatment parameters.
Clinical evidence and results:
Studies have shown that PicoWay lasers can deliver:
Removal of multi-coloured tattoos, including difficult-to-treat blue and green tattoos1,2
High rates of improvement in wrinkle severity3,4
Reduced acne scarring after just three treatments5
A high rate of benign pigmented lesion clearance6
Disclaimer: All contents of this material are for informational purposes only and provided by Candela Asia-Pacific without warranties of any kind. Healthcare professionals are solely responsible for making their own independent evaluation as to the suitability of any product for any particular purpose and in accordance with country-specific regulations. The availability of products and the indications mentioned in this material is subject to the regulatory requirements and product registration status in each country. Refer to the User Manual for country-specific indications. Products and technical specifications may change without notice. Please contact Candela Asia-Pacific for more details.
©2021 Candela Corporation. This material contains registered and unregistered trademarks, trade-names, service marks and brand names of Candela Corporation and its affiliates. All other trademarks are the property of their respective owners. All rights reserved.
NOT ALL PRODUCTS ARE LICENSED IN YOUR COUNTRY, PLEASE CHECK WITH YOUR LOCAL REPRESENTATIVE. ALL PERSONAL DATA SUBMITTED TO CANDELA VIA THIS WEBSITE WILL BE HELD IN ACCORDANCE WITH OUR PRIVACY NOTICE, WHICH CAN BE VIEWED HERE. © 2021 CANDELA CORPORATION. ALL RIGHT RESERVED.